LinkedIn logo

Seth J. Baum MD, MASPC, FACC, FAHA, FNLA

Chief Medical Officer

Dr. Seth J. Baum is a graduate of Columbia College and Columbia College of Physicians and Surgeons with training in Internal Medicine, Cardiology, Interventional Cardiology, and Electrophysiology.

Dr. Baum is a past President and Master of the American Society for Preventive Cardiology and a fellow of the American College of Cardiology, the American Heart Association, the American College of Preventive Medicine, and the National Lipid Association. He currently sits on The Family Heart Foundation Board and serves as its Vice Chair. He has published over 150 peer-reviewed papers and abstracts – many in top-tier journals such as the New England Journal of Medicine, JAMA, Lancet, JACC, and Nature – as well as two books.

In 2013, he was awarded Cleveland Heart Lab’s “Heart Award” for lifelong dedication to Preventive Medicine. In 2019, Mended Hearts honored him with its biennial Dwight Emary Harken Award. Dr. Baum is the Founder of Excel Medical Clinical Trials. As a Principal Investigator in novel drug development, he has contributed significantly to the advancement of therapeutics in disease states ranging from ultra-rare to common.

Dr. Baum is a clinical affiliate professor of Cardiology at FAU Medical School. He runs the only Lipoprotein Apheresis center in southeast Florida and consults in Clinical Lipidology and Preventive Cardiology.

“It has been a privilege to help thousands of patients during my nearly 40-year career in Medicine. Working in clinical research, however, has enabled me to dramatically expand my reach. Participating in clinical trials, I have been fortunate to help bring life-saving medications to literally millions of people. Flourish Research fosters excellence in all aspects of the conduct of clinical trials and I am proud to be a part of the company.”

Contact us about your next trial at bd@flourishresarch.com.

Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.